Chapter 1. Research Scope
1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
1.4.1. Market size breakdown, by application
1.4.2. Market size breakdown, by product type
1.4.3. Market size breakdown, by type
1.4.4. Market size breakdown, by disease
1.4.5. Market size breakdown, by region
1.4.6. Market size breakdown, by country
1.5. Market Data Reporting Unit
1.5.1. Value
1.6. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.1.1. Paid
2.1.2. Unpaid
2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
Chapter 6. Industry Outlook
6.1. Market Dynamics
6.1.1. Trends
6.1.2. Drivers
6.1.3. Restraints/challenges
6.1.4. Impact analysis of drivers/restraints
6.2. Impact of COVID-19
6.3. Porter’s Five Forces Analysis
6.3.1. Bargaining power of buyers
6.3.2. Bargaining power of suppliers
6.3.3. Threat of new entrants
6.3.4. Intensity of rivalry
6.3.5. Threat of substitutes
Chapter 7. Global Market
7.1. Overview
7.2. Market Revenue, by Application (2019–2030)
7.3. Market Revenue, by Product type (2019–2030)
7.4. Market Revenue, by Type (2019–2030)
7.5. Market Revenue, by Disease (2019–2030)
7.6. Market Revenue, by Region (2019–2030)
Chapter 8. North America Market
8.1. Overview
8.2. Market Revenue, by Application (2019–2030)
8.3. Market Revenue, by Product type (2019–2030)
8.4. Market Revenue, by Type (2019–2030)
8.5. Market Revenue, by Disease (2019–2030)
8.6. Market Revenue, by Country (2019–2030)
Chapter 9. Europe Market
9.1. Overview
9.2. Market Revenue, by Application (2019–2030)
9.3. Market Revenue, by Product type (2019–2030)
9.4. Market Revenue, by Type (2019–2030)
9.5. Market Revenue, by Disease (2019–2030)
9.6. Market Revenue, by Country (2019–2030)
Chapter 10. APAC Market
10.1. Overview
10.2. Market Revenue, by Application (2019–2030)
10.3. Market Revenue, by Product type (2019–2030)
10.4. Market Revenue, by Type (2019–2030)
10.5. Market Revenue, by Disease (2019–2030)
10.6. Market Revenue, by Country (2019–2030)
Chapter 11. LATAM Market
11.1. Overview
11.2. Market Revenue, by Application (2019–2030)
11.3. Market Revenue, by Product type (2019–2030)
11.4. Market Revenue, by Type (2019–2030)
11.5. Market Revenue, by Disease (2019–2030)
11.6. Market Revenue, by Country (2019–2030)
Chapter 12. MEA Market
12.1. Overview
12.2. Market Revenue, by Application (2019–2030)
12.3. Market Revenue, by Product type (2019–2030)
12.4. Market Revenue, by Type (2019–2030)
12.5. Market Revenue, by Disease (2019–2030)
12.6. Market Revenue, by Country (2019–2030)
Chapter 13. U.S. Market
13.1. Overview
13.2. Market Revenue, by Application (2019–2030)
13.3. Market Revenue, by Product type (2019–2030)
13.4. Market Revenue, by Type (2019–2030)
13.5. Market Revenue, by Disease (2019–2030)
Chapter 14. Canada Market
14.1. Overview
14.2. Market Revenue, by Application (2019–2030)
14.3. Market Revenue, by Product type (2019–2030)
14.4. Market Revenue, by Type (2019–2030)
14.5. Market Revenue, by Disease (2019–2030)
Chapter 15. Germany Market
15.1. Overview
15.2. Market Revenue, by Application (2019–2030)
15.3. Market Revenue, by Product type (2019–2030)
15.4. Market Revenue, by Type (2019–2030)
15.5. Market Revenue, by Disease (2019–2030)
Chapter 16. France Market
16.1. Overview
16.2. Market Revenue, by Application (2019–2030)
16.3. Market Revenue, by Product type (2019–2030)
16.4. Market Revenue, by Type (2019–2030)
16.5. Market Revenue, by Disease (2019–2030)
Chapter 17. U.K. Market
17.1. Overview
17.2. Market Revenue, by Application (2019–2030)
17.3. Market Revenue, by Product type (2019–2030)
17.4. Market Revenue, by Type (2019–2030)
17.5. Market Revenue, by Disease (2019–2030)
Chapter 18. Italy Market
18.1. Overview
18.2. Market Revenue, by Application (2019–2030)
18.3. Market Revenue, by Product type (2019–2030)
18.4. Market Revenue, by Type (2019–2030)
18.5. Market Revenue, by Disease (2019–2030)
Chapter 19. Spain Market
19.1. Overview
19.2. Market Revenue, by Application (2019–2030)
19.3. Market Revenue, by Product type (2019–2030)
19.4. Market Revenue, by Type (2019–2030)
19.5. Market Revenue, by Disease (2019–2030)
Chapter 20. Japan Market
20.1. Overview
20.2. Market Revenue, by Application (2019–2030)
20.3. Market Revenue, by Product type (2019–2030)
20.4. Market Revenue, by Type (2019–2030)
20.5. Market Revenue, by Disease (2019–2030)
Chapter 21. China Market
21.1. Overview
21.2. Market Revenue, by Application (2019–2030)
21.3. Market Revenue, by Product type (2019–2030)
21.4. Market Revenue, by Type (2019–2030)
21.5. Market Revenue, by Disease (2019–2030)
Chapter 22. India Market
22.1. Overview
22.2. Market Revenue, by Application (2019–2030)
22.3. Market Revenue, by Product type (2019–2030)
22.4. Market Revenue, by Type (2019–2030)
22.5. Market Revenue, by Disease (2019–2030)
Chapter 23. Australia Market
23.1. Overview
23.2. Market Revenue, by Application (2019–2030)
23.3. Market Revenue, by Product type (2019–2030)
23.4. Market Revenue, by Type (2019–2030)
23.5. Market Revenue, by Disease (2019–2030)
Chapter 24. South Korea Market
24.1. Overview
24.2. Market Revenue, by Application (2019–2030)
24.3. Market Revenue, by Product type (2019–2030)
24.4. Market Revenue, by Type (2019–2030)
24.5. Market Revenue, by Disease (2019–2030)
Chapter 25. Brazil Market
25.1. Overview
25.2. Market Revenue, by Application (2019–2030)
25.3. Market Revenue, by Product type (2019–2030)
25.4. Market Revenue, by Type (2019–2030)
25.5. Market Revenue, by Disease (2019–2030)
Chapter 26. Mexico Market
26.1. Overview
26.2. Market Revenue, by Application (2019–2030)
26.3. Market Revenue, by Product type (2019–2030)
26.4. Market Revenue, by Type (2019–2030)
26.5. Market Revenue, by Disease (2019–2030)
Chapter 27. Saudi Arabia Market
27.1. Overview
27.2. Market Revenue, by Application (2019–2030)
27.3. Market Revenue, by Product type (2019–2030)
27.4. Market Revenue, by Type (2019–2030)
27.5. Market Revenue, by Disease (2019–2030)
Chapter 28. South Africa Market
28.1. Overview
28.2. Market Revenue, by Application (2019–2030)
28.3. Market Revenue, by Product type (2019–2030)
28.4. Market Revenue, by Type (2019–2030)
28.5. Market Revenue, by Disease (2019–2030)
Chapter 29. U.A.E. Market
29.1. Overview
29.2. Market Revenue, by Application (2019–2030)
29.3. Market Revenue, by Product type (2019–2030)
29.4. Market Revenue, by Type (2019–2030)
29.5. Market Revenue, by Disease (2019–2030)
Chapter 30. Competitive Landscape
30.1. List of Market Players and their Offerings
30.2. Competitive Benchmarking of Key Players
30.3. Product Benchmarking of Key Players
30.4. Recent Strategic Developments
Chapter 31. Company Profiles
31.1. PerkinElmer AES
31.1.1. Business overview
31.1.2. Product and service offerings
31.1.3. Key financial summary
31.2. Abbott Laboratories
31.2.1. Business overview
31.2.2. Product and service offerings
31.2.3. Key financial summary
31.3. Thermo Fisher Scientific Inc
31.3.1. Business overview
31.3.2. Product and service offerings
31.3.3. Key financial summary
31.4. F. Hoffmann-La Roche Ltd
31.4.1. Business overview
31.4.2. Product and service offerings
31.4.3. Key financial summary
31.5. Bio-Rad Laboratories, Inc
31.5.1. Business overview
31.5.2. Product and service offerings
31.5.3. Key financial summary
31.6. Epigenomics AG
31.6.1. Business overview
31.6.2. Product and service offerings
31.6.3. Key financial summary
31.7. Merck KGaA
31.7.1. Business overview
31.7.2. Product and service offerings
31.7.3. Key financial summary
31.8. Agilent Technologies, Inc
31.8.1. Business overview
31.8.2. Product and service offerings
31.8.3. Key financial summary
31.9. GE Healthcare Technologies Inc
31.9.1. Business overview
31.9.2. Product and service offerings
31.9.3. Key financial summary
31.10. Siemens Healthineers AG
31.10.1. Business overview
31.10.2. Product and service offerings
31.10.3. Key financial summary
31.11. QIAGEN N.V.
31.11.1. Business overview
31.11.2. Product and service offerings
31.11.3. Key financial summary
31.12. Sino Biological, Inc
31.12.1. Business overview
31.12.2. Product and service offerings
31.12.3. Key financial summary
31.13. Meso Scale Diagnostics, LLC
31.13.1. Business overview
31.13.2. Product and service offerings
31.14. ENZO Biochem, Inc
31.14.1. Business overview
31.14.2. Product and service offerings
31.14.3. Key financial summary
31.15. Epistem Limited
31.15.1. Business overview
31.15.2. Product and service offerings
Chapter 32. Appendix
32.1. Abbreviations
32.2. Sources and References
32.3. Related Reports
Want a report tailored exactly to your business need?
Request CustomizationWe are Trusted by
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages